News & Updates

Adding intrauterine misoprostol to oxytocin significantly reduced the incidence of postpartum haemorrhage (PPH) in women who underwent caesarean section (CS) compared with oxytocin alone, according to a study presented at RCOG 2024.

In the management of preterm premature rupture of membranes (PPROM), a combination therapy of fosfomycin, clindamycin, and metronidazole has shown superiority over erythromycin plus metronidazole, while azithromycin has emerged as a promising alternative to erythromycin, with both regimens associated with favourable outcomes, as shown in two studies presented at RCOG 2024.

Evidence from a large population-based study shows no consistent association between an increased risk of cancer and exposure to antihypertensive drugs.

Women with early-stage breast cancer (BC) entering randomized controlled trials (RCTs) after the 2000s have reduced rates of distant recurrence vs the 1990s, a patient-level pooled analysis by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) has shown. 

Among older adults with hearing loss, provision of hearing aids and other interventions do not appear to significantly improve health-related quality of life (HRQoL) outcomes over 3 years of follow-up, as reported in a study.

Treatment with high-dose VE303, a defined bacterial consortium composed of eight strains of commensal Clostridia, was associated with a significant reduction in antibiotic resistance genes (ARGs) among individuals with Clostridioides difficile infection (CDI), according to the phase II CONSORTIUM* study presented at IDWeek 2024.